Carcinoid tumors

Current Treatment Options in Oncology

Volumn 3, Issue 4, 2002, Pages 319-326

  Boushey, Robin P ^a   Dackiw, Alan P B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Carcinoid Syndrome; Carcinoid Tumor; Lanreotide; Octreotide; Rectal Carcinoid

Indexed keywords

ANTINEOPLASTIC AGENT;

CARCINOID; CARCINOID SYNDROME; CLINICAL TRIAL; HEPATIC ARTERY; HUMAN; LIVER TUMOR; METASTASIS; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOID TUMOR; CLINICAL TRIALS; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALIGNANT CARCINOID SYNDROME;

EID: 0036673492     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-002-0031-2     Document Type: Article

References (30)

1. Kulke MH, Mayer RJ: Carcinoid tumors. N Engl J Med 1999, 340:858–868. DOI: 10.1056/NEJM199903183401107
2. Ganim RB, Norton JA: Recent advances in carcinoid pathogenesis, diagnosis and management. Surg Oncol 2000, 9:173–179. DOI: 10.1016/S0960-7404(01)00007-X
3. Lucas KJ, Feldman JM: Flushing in the carcinoid syndrome and plasma kallikrein. Cancer 1986, 58:2290–2293. DOI: 10.1002/1097-0142(19861115)58:10<2290::AID-CNCR2820581022>3.0.CO;2-4
4. Eriksson B, Oberg K, Stridsberg M: Tumor markers in neuroendocrine tumors. Digestion 2000, 62:33–38. DOI: 10.1159/000051853
5. Reubi JC, Laissue J, Waser B, et al.: Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci 1994, 733:122–137. DOI: 10.1111/j.1749-6632.1994.tb17262.x
6. Rea F, Binda R, Spreafico G, et al.: Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg 1989, 47:412–414. DOI: 10.1016/0003-4975(89)90383-4
7. Schreurs AJ, Westermann CJ, van den Bosch JM, et al.: A twenty-five-year follow-up of ninety-three resected typical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1992, 104:1470–1475.
8. Solcia E, Capella C, Fiocca R, et al.: Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia: a newly recognized association. Am J Surg Pathol 1990, 14:503–513. DOI: 10.1097/00000478-199006000-00001
9. Lehy T, Cadiot G, Mignon M, et al.: Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992, 33:1275–1279.
10. Moses RE, Frank BB, Leavitt M, Miller R: The syndrome of type A chronic atrophic gastritis, pernicious anemia, and multiple gastric carcinoids. J Clin Gastroenterol 1986, 8:61–65. DOI: 10.1097/00004836-198602000-00013
11. Barclay TH, Schapira DV: Malignant tumors of the small intestine. Cancer 1983, 51:878–881. DOI: 10.1002/1097-0142(19830301)51:5<878::AID-CNCR2820510521>3.0.CO;2-V
12. Makridis C, Oberg K, Juhlin C, et al.: Surgical treatment of mid-gut carcinoid tumors. World J Surg 1990, 14:377–383. DOI: 10.1007/BF01658532
13. Moertel CG, Dockerty MB, Judd ES: Carcinoid tumors of the vermiform appendix. Cancer 1968, 21:270–278. DOI: 10.1002/1097-0142(196802)21:2<270::AID-CNCR2820210217>3.0.CO;2-9
14. Moertel CG, Weiland LH, Nagorney DM, Dockerty MB: Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987, 317:1699–1701. DOI: 10.1056/NEJM198712313172704
15. Berardi RS: Carcinoid tumors of the colon (exclusive of the rectum): review of the literature. Dis Colon Rectum 1972, 15:383–391. DOI: 10.1007/BF02587418
16. Jetmore AB, Ray JE, Gathright JB Jr, et al.: Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum 1992, 35:717–725. DOI: 10.1007/BF02050318
17. Naunheim KS, Zeitels J, Kaplan EL, et al.: Rectal carcinoid tumors—treatment and prognosis. Surgery 1983, 94:670–676.
18. Burke M, Shepherd N, Mann CV: Carcinoid tumours of the rectum and anus. Br J Surg 1987, 74:358–361. DOI: 10.1002/bjs.1800740509
19. Eriksson B, Oberg K: Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: future outlook. Ann Oncol 1999, 10:S31-S38. DOI: 10.1023/A:1027352531144
20. Kubota A, Yamada Y, Kagimoto S, et al.: Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994, 93:1321–1325. DOI: 10.1172/JCI117090
21. Kvols LK, Moertel CG, O’Connell MJ, et al.: Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1986, 315:663–666. DOI: 10.1056/NEJM198609113151102
22. Tomassetti P, Migliori M, Corinaldesi R, Gullo L: Treatment of gastroenteropancreatic neuroendocrine tumours with octreotide LAR. Aliment Pharmacol Ther 2000, 14:557–560. DOI: 10.1046/j.1365-2036.2000.00738.x
23. O’Toole D, Ducreux M, Bommelaer G, et al.: Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 2000, 88:770–776. DOI: 10.1002/(SICI)1097-0142(20000215)88:4<770::AID-CNCR6>3.0.CO;2-0
24. Rubin J, Ajani J, Schirmer W, et al.: Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol 1999, 17:600–606.
25. Moertel CG, Hanley JA: Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials 1979, 2:327–334.
26. Engstrom PF, Lavin PT, Moertel CG, et al.: Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 1984, 2:1255–1259.
27. Bukowski RM, Johnson KG, Peterson RF, et al.: A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors: a Southwest Oncology Group Study. Cancer 1987, 60:2891–2895. DOI: 10.1002/1097-0142(19871215)60:12<2891::AID-CNCR2820601207>3.0.CO;2-6
28. Moertel CG, Kvols LK, O’Connell MJ, Rubin J: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991, 68:227–232. DOI: 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I
29. Moertel CG, Johnson CM, McKusick MA, et al.: The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994, 120:302–309.
30. Schupak KD, Wallner KE: The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors. Int J Radiat Oncol Biol Phys 1991, 20:489–495.